CD24 and cancer: The 4-hour time point also appears to be the optimum duration for the separation and enrichment of the breast CSCs (as denoted by the phenotype of CD44+CD24−/lowESA+) from the heterogeneous MCF7 cancer cells and the primary cells under static culture conditions.